Nabil E. Omar
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study).
Journal: Frontiers in immunology
Published: June 07, 2026
Effect of RAS Pathway Gene Mutations on Survival in Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 10, 2026
The association between DNA repair genes polymorphisms and cisplatin-induced ototoxicity in cancer patients: a systematic review.
Journal: Personalized medicine
Published: January 14, 2026
Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: November 26, 2025
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study).
Journal: Frontiers in immunology
Published: July 14, 2025
Global Landscape of the Attack of Predatory Journals in Oncology.
Journal: JCO global oncology
Published: May 23, 2024
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study.
Journal: Clinical Medicine Insights. Oncology
Published: January 14, 2024
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials.
Journal: Frontiers in oncology
Published: August 29, 2023
Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
Journal: Frontiers in endocrinology
Published: August 29, 2023
Early predictors of intensive care unit admission among COVID-19 patients in Qatar.
Journal: Frontiers in public health
Published: August 15, 2023
Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature.
Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature.
Journal: Frontiers in oncology
Published: August 09, 2023
Cisplatin-induced ototoxicity: a novel approach to an ancient problem.
Journal: Pharmacogenetics and genomics
Published: April 17, 2023
Last Updated: 09/26/2026